Comparison between Euro Pratik Sales IPO and Gaudium IVF IPO.
Euro Pratik Sales IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Gaudium IVF IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Euro Pratik Sales IPO is up to ₹451.31 Cr whereas the issue size of the Gaudium IVF IPO is up to ₹165.00 Cr. The final issue price of Euro Pratik Sales IPO is ₹247.00 per share and of Gaudium IVF IPO is ₹79.00 per share.
| Euro Pratik Sales IPO | Gaudium IVF IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹5 per share |
| Issue Price (Lower) | ₹235.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹247.00 per share | ₹79.00 per share |
| Issue Price (Final) | ₹247.00 per share | ₹79.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹13.00 per share | |
| Market Lot Size | 60 shares | 189 shares |
| Fresh Issue Size | 0 shares | 1,13,92,500 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹90.00 Cr |
| OFS Issue Size | 1,82,74,798 shares | 94,93,700 shares |
| OFS Issue Size (Amount) | up to ₹451.31 Cr | up to ₹75.00 Cr |
| Issue Size Total | 1,82,74,798 shares | 2,08,86,200 shares |
| Issue Size Total (Amount) | up to ₹451.31 Cr | up to ₹165.00 Cr |
Euro Pratik Sales IPO opens on Sep 16, 2025, while Gaudium IVF IPO opens on Feb 20, 2026. The closing date of Euro Pratik Sales IPO and Gaudium IVF IPO is Sep 18, 2025, and Feb 24, 2026, respectively.
| Euro Pratik Sales IPO | Gaudium IVF IPO | |
|---|---|---|
| Anchor Bid Date | Sep 15, 2025 | Feb 19, 2026 |
| Issue Open | Sep 16, 2025 | Feb 20, 2026 |
| Issue Close | Sep 18, 2025 | Feb 24, 2026 |
| Basis Of Allotment (Tentative) | Sep 19, 2025 | Feb 25, 2026 |
| Initiation of Refunds (Tentative) | Sep 22, 2025 | Feb 25, 2026 |
| Credit of Share (Tentative) | Sep 22, 2025 | Feb 26, 2026 |
| Listing date (Tentative) | Sep 23, 2025 | Feb 27, 2026 |
| Anchor Lockin End date 1 | Oct 18, 2025 | Mar 26, 2026 |
| Anchor Lockin End date 2 | Dec 17, 2025 | May 25, 2026 |
Euro Pratik Sales IPO P/E ratio is 33.02, as compared to Gaudium IVF IPO P/E ratio of 25.36.
| Euro Pratik Sales IPO | Gaudium IVF IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Euro Pratik Sales Ltd.'s revenue increased by 27% and profit after tax (PAT) rose by 22% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 87.97 | 99.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.1 | 71.30 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 33.02 | 25.36 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2524.34 Cr. | ₹575.02 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 39.18% | 41.31% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 44.58% | 39.70% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.01 | 0.41 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.48 | ₹3.12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 32.60% | 41.71% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Euro Pratik Sales IPO Retail Individual Investors (RII) are offered 63,75,313 shares while in Gaudium IVF IPO retail investors are offered 63,75,313 shares. Qualified Institutional Buyers (QIB) are offered 36,43,036 shares in Euro Pratik Sales IPO and 41,77,240 shares in Gaudium IVF IPO.
| Euro Pratik Sales IPO | Gaudium IVF IPO | |
|---|---|---|
| Anchor Investor Reservation | 54,64,554 shares | 62,65,860 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 36,43,036 shares | 41,77,240 shares |
| NII | 27,32,277 shares | 31,32,930 shares |
| RII | 63,75,313 shares | 73,10,170 shares |
| Employee | 59,827 shares | 0 shares |
| Others | ||
| Total | 1,82,75,007 shares | 2,08,86,200 shares |
Euro Pratik Sales IPO subscribed 1.41x in total, whereas Gaudium IVF IPO subscribed 7.27x.
| Euro Pratik Sales IPO | Gaudium IVF IPO | |
|---|---|---|
| QIB (times) | 1.10x | 1.62x |
| NII (times) | 2.02x | 14.05x |
| Big NII (times) | 2.35x | 12.71x |
| Small NII (times) | 1.35x | 16.73x |
| RII (times) | 1.31x | 7.60x |
| Employee (times) | 4.09x | |
| Other (times) | ||
| Total (times) | 1.41x | 7.27x |
